NEWS IN BRIEF
Selexis and Symphogen expand partnership to progress two mAbs
Selexis and Symphogen have announced that the latter has submitted INDs for clinical programmes to progress two mAbs using Selexis’ platform.
Archives for July 11, 2018
Pluristem brings in Thermo Fisher to ‘transform cell therapy manufacturing’
Pluristem Therapeutics has announced that it has agreed a strategic collaboration with Thermo Fisher to improve the process by which cell therapies are manufactured.
Forbion looks to take advantage of 'undersupply' of capital to European life sciences
Forbion has raised €270m in an investment fund, exceeding its target, and will now build a portfolio of 15 companies.